Alliance Pharma plc (LON:APH) insider Peter Butterfield sold 61,846 shares of the business’s stock in a transaction dated Tuesday, February 14th. The shares were sold at an average price of GBX 49 ($0.61), for a total value of £30,304.54 ($37,871.21).

Shares of Alliance Pharma plc (LON:APH) opened at 49.125 on Friday. The stock has a 50 day moving average price of GBX 48.26 and a 200 day moving average price of GBX 47.08. The stock’s market capitalization is GBX 230.05 million. Alliance Pharma plc has a 12-month low of GBX 40.50 and a 12-month high of GBX 55.41.

“Peter Butterfield Sells 61,846 Shares of Alliance Pharma plc (APH) Stock” was originally reported by Watch List News and is the sole property of of Watch List News. If you are reading this piece of content on another domain, it was copied illegally and republished in violation of US and international trademark and copyright laws. The correct version of this piece of content can be accessed at http://www.watchlistnews.com/peter-butterfield-sells-61846-shares-of-alliance-pharma-plc-aph-stock/1121446.html.

Separately, Numis Securities Ltd reissued a “buy” rating and issued a GBX 60 ($0.75) target price on shares of Alliance Pharma plc in a report on Monday, January 23rd.

Alliance Pharma plc Company Profile

Alliance Pharma plc is a United Kingdom-based specialty pharmaceutical company. The Company is engaged in acquisition, marketing and distribution of pharmaceutical products. The Company operates in various business areas, such as Hydromol, secondary care, community and consumer products, established products and international.

Receive News & Ratings for Alliance Pharma plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alliance Pharma plc and related companies with Analyst Ratings Network's FREE daily email newsletter.